Rushnet, Inc and its Subsidiaries heliosDX and Grandeza Healthcare Provide an Update on the Ongoing PCAOB Accredited Audit

ALPHARETTA, GA / ACCESSWIRE / February 18, 2022 / RushNet, Inc (OTC PINK:RSHN), (the "Company") and its subsidiaries heliosDX and Grandeza Healthcare is pleased to announce the current ongoing audit being conducted by Somerset CPAs and Advisors is progressing nicely and as expected.

We are concluding the fifth week of the audit. The team at Somerset has already conducted one weeklong field visit to Alpharetta, GA. The team at Somerset potentially may have another field visit to our executive headquarters in Jacksonville, Florida, but this is yet to be determined.

The audit team stated they have exceeded the halfway point but there is still work to be done. We will continue to update along the way as the audit progresses via our media pages, namely Twitter. As necessary, we will update the market by issuing a press release when warranted.

Ashley Sweat CEO of Rushnet, Inc and heliosDX, would like to especially say thank you to Grandeza Healthcare and Whirley & Associates for their tireless efforts and around the clock responses to the Somerset audit team. This effort is critical to the summer plans of maximizing value for our shareholders.

Somerset CPAs and Advisors is a national firm operating in all 50 states with more than 600 associates. They were named a Top 200 Firm in 2019 and 2020.

About HeliosDx:

heliosDX is a National Clinical Reference Laboratory offering High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. We are contracted in 44 of the lower 48 states and looking to expand our reach and capabilities. We intend to always stay ahead of the curve by continually investing in our infrastructure with the most efficient scientific proven instruments and latest cutting-edge software for patient and physician satisfaction. In management's opinion, following such best practices are intended to allow heliosDX to provide physicians fast and accurate reporting, meeting, and exceeding industry benchmarks. It is our goal to excel in patient and client care through physician designed panels that aid in testing compliance and reporting education.

Contact: Ashley Sweat
asweat@heliosdx.com
www.heliosdx.com
Twitter Handle: @dx_helios

About Grandeza Healthcare:

Grandeza Healthcare is a healthcare billing and consulting company. Providing expert billing and coding services to laboratories, medical practices, dental offices, and other medical verticals. In addition to billing, we provide Revenue Cycle Management (RCM) for all clients, as well as customized consulting services. We are a rapidly growing company adding new services and value to further demonstrate our competitive advantage.

Contact: Danielle Bauer
dbauer@grandezahc.com
www.grandezahc.com
Twitter Handle: @GrandezaHC

Safe Harbor Notice

Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). The Company cautions that statements, and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. The Companies undertake no obligation to revise these statements following the date of this news release.

Investor caution/added risk for investors in companies claiming involvement in COVID-19 initiatives -

On April 8, 2020, SEC Chairman Jay Clayton and William Hinman, the Director of the Division of Corporation Finance, issued a joint public statement on the importance of disclosure during the COVID-19 crisis.

The SEC and Self-Regulatory Organizations are targeting public companies that claim to have products, treatment, or other strategies with regard to COVID-19.

The ultimate impact of the COVID-19 pandemic on the Company's operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak. Additionally, new information may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time.

We further caution investors that our primary focus and goal is to battle this pandemic for the good of the world. As such, it is possible that we may find it necessary to make disclosures which are consistent with that goal, but which may be averse to the pecuniary interests of the Company and of its shareholders.

SOURCE: RushNet, Inc.